Approval · Notice of Compliance 6462 · 2000
ALAMYCIN LP INJECTABLE SOLUTION: Notice of Compliance 6462
Issued May 12, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 6462
- Date
- May 12, 2000
- Company
- Norbrook Laboratories Ltd.Newry, Northern Ireland, United Kingdom
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in formulation
- Therapeutic class
- Antibiotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ALAMYCIN LP INJECTABLE SOLUTION | 00507253 | Cancelled Post Market |
Medicinal ingredients
- OXYTETRACYCLINE HCL 100 MG per ML